Insulin glargine and lixisenatide and Stelara (Ustekinumab Intravenous Infusion)
Determining the interaction of Insulin glargine and lixisenatide and Stelara (Ustekinumab Intravenous Infusion) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
Generic Name: ustekinumab
Brand name: Stelara, Stelara PFS
Synonyms: Stelara
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide-Stelara (Ustekinumab Subcutaneous Injection)
- Insulin glargine and lixisenatide-Stelazine
- Insulin glargine and lixisenatide-Stemetic
- Insulin glargine and lixisenatide-Stemetil
- Insulin glargine and lixisenatide-Stendra
- Insulin glargine and lixisenatide-Sterapred
- Stelara (Ustekinumab Intravenous Infusion)-Insulin glargine and lixisenatide Subcutaneous
- Stelara (Ustekinumab Intravenous Infusion)-Insulin glargine, recombinant Subcutaneous
- Stelara (Ustekinumab Intravenous Infusion)-Insulin glulisine
- Stelara (Ustekinumab Intravenous Infusion)-Insulin Glulisine (Cartridges and Pens)
- Stelara (Ustekinumab Intravenous Infusion)-Insulin Glulisine (Vials)
- Stelara (Ustekinumab Intravenous Infusion)-Insulin glulisine Subcutaneous